Literature DB >> 8761722

Rifamycin resistance in mycobacteria.

S T Cole1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8761722     DOI: 10.1016/0923-2508(96)80203-8

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


× No keyword cloud information.
  9 in total

Review 1.  Genetics and pulmonary medicine. 5. Genetics of drug resistant tuberculosis.

Authors:  A Telenti
Journal:  Thorax       Date:  1998-09       Impact factor: 9.139

2.  Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level.

Authors:  A Telenti; N Honoré; C Bernasconi; J March; A Ortega; B Heym; H E Takiff; S T Cole
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  Characterization of mutations in the rpoB gene in naturally rifampin-resistant Rickettsia species.

Authors:  M Drancourt; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

4.  Different rifampin sensitivities of Escherichia coli and Mycobacterium tuberculosis RNA polymerases are not explained by the difference in the beta-subunit rifampin regions I and II.

Authors:  N Zenkin; A Kulbachinskiy; I Bass; V Nikiforov
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

5.  Application of genotype MTBDRplus in rapid detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin in a high volume laboratory in Southern China.

Authors:  Lei Zhang; Yuanxing Ye; Lina Duo; Tingting Wang; Xingbo Song; Xiaojun Lu; Binwu Ying; Lanlan Wang
Journal:  Mol Biol Rep       Date:  2010-09-18       Impact factor: 2.316

6.  Interaction of CarD with RNA polymerase mediates Mycobacterium tuberculosis viability, rifampin resistance, and pathogenesis.

Authors:  Leslie A Weiss; Phillip G Harrison; Bryce E Nickels; Michael S Glickman; Elizabeth A Campbell; Seth A Darst; Christina L Stallings
Journal:  J Bacteriol       Date:  2012-08-17       Impact factor: 3.490

7.  Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.

Authors:  Belay Tessema; Joerg Beer; Frank Emmrich; Ulrich Sack; Arne C Rodloff
Journal:  BMC Infect Dis       Date:  2012-02-10       Impact factor: 3.090

8.  Rifamycin O, An Alternative Anti-Mycobacterium abscessus Agent.

Authors:  Bui Thi Bich Hanh; June-Woo Park; Tae Ho Kim; Jae-Sung Kim; Chul-Su Yang; Kiseok Jang; Jinsheng Cui; Dong-Chan Oh; Jichan Jang
Journal:  Molecules       Date:  2020-03-31       Impact factor: 4.411

9.  Detection of multidrug-resistant Mycobacterium tuberculosis strains isolated in Brazil using a multimarker genetic assay for katG and rpoB genes.

Authors:  Luita Nice Café Oliveira; Jairo da Silva Muniz-Sobrinho; Luiz Alexandre Viana-Magno; Sônia Cristina Oliveira Melo; Antonio Macho; Fabrício Rios-Santos
Journal:  Braz J Infect Dis       Date:  2016-02-10       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.